-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Nabriva Therapeutics (NASDAQ:NBRV) Now Covered by StockNews.com
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Stock Down 100.0 % Nabriva Therapeutics has a 1 year low of $1.22 and a 1 year high of $8.45. The […]
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Stock Down 100.0 % Nabriva Therapeutics has a 1 year low of $1.22 and a 1 year high of $8.45. The […]
